Paracetamol Clinical Trials

8 recruitingLast updated: July 25, 2026

There are 8 actively recruiting paracetamol clinical trials across 3 countries. Studies span Phase 3, Not Applicable, Phase 4. Top locations include Cairo, Cairo Governorate, Egypt, Ghent, Belgium. Updated daily from ClinicalTrials.gov.


Paracetamol Trials at a Glance

8 actively recruiting trials for paracetamol are listed on ClinicalTrialsFinder across 2 cities in 3 countries. The largest study group is Phase 3 with 2 trials, with the heaviest enrollment activity in Cairo and Ghent. Lead sponsors running paracetamol studies include Monash Health, Cairo University, and Colin Page.

Browse paracetamol trials by phase

Top cities for paracetamol trials

Treatments under study

About Paracetamol Clinical Trials

Looking for clinical trials for Paracetamol? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Paracetamol trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Paracetamol clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Paracetamol and Cefazolin Pharmacokinetics in Normal Weight and Overweight Children

ParacetamolCefazolin
University Hospital, Ghent120 enrolled1 locationNCT07585487
Recruiting
Not Applicable

Hemodynamic Effects of Intravenous Paracetamol in Patients Undergoing Emergency Laparotomy

Emergency surgeryHypotension Drug-InducedParacetamol
Cairo University90 enrolled1 locationNCT07466108
Recruiting

Paracetamol and Patent Ductus Arteriosus closure: Pharmacokinetic-Pharmacodynamic study

Patent Ductus Arteriosus (PDA) in preterm neonatesParacetamol therapy for PDA closure.
Monash Health50 enrolled1 locationACTRN12623001197628
Recruiting
Phase 3

The NACSTOP 2 trial: Investigation of the early cessation of N-acetylcysteine in patients following paracetamol overdose.

paracetamol overdose
Monash Health200 enrolled6 locationsACTRN12619001549112
Recruiting
Phase 3

Double NAC trial: Investigation of increased N-acetylcysteine dosing in patients treated for paracetamol overdose.

paracetamol overdose
Monash Health230 enrolled6 locationsACTRN12619001548123
Recruiting

Efficacy of a two bag N-acetylcysteine(NAC) regimen to treat paracetamol overdose (2NAC study).

paracetamol overdose
Monash Health3,000 enrolled10 locationsACTRN12617000973314
Recruiting
Phase 4

A comparison of two different durations of the antidote acetylcysteine for paracetamol overdose.

Paracetamol toxicity
Colin Page220 enrolled3 locationsACTRN12616001617459
Recruiting

Effect of Varying Body Weight on the Pharmacokinetics of Paracetamol in Children

Pharmacokinetics of paracetamol in obesity
University of South Australia273 enrolled1 locationACTRN12610000997055